Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Most Korean systemic lupus erythematosus patients experienced hair loss, often as non-scarring diffuse hair loss, with non-scarring patch alopecia also common.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

Dupilumab may help regrow hair in people with atopic dermatitis.

Oral cyclosporine can help regrow hair in severe alopecia areata cases.

Lack of small, fine hair on the front hairline is a key sign of frontal fibrosing alopecia.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.

Alopecia Areata might be linked to Crohn's disease.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

COVID-19 infection may trigger alopecia areata in some patients.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Alopecia areata patients often have low vitamin D levels.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

IL-10 may worsen alopecia areata instead of helping it.

Alopecia Areata (AA) causes significant emotional distress, including feelings of embarrassment, depression, and anxiety, and impacts social interactions and daily activities.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

308-nm excimer laser therapy helps regrow hair in alopecia areata.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Gonadal hormones significantly affect the severity of alopecia areata in mice.